Journal of Oriental Neuropsychiatry (동의신경정신과학회지)

The Korean Society of Oriental Neuropsychiatry (대한한방신경정신과학회)
권호 표지

The effects of Hyangbujapalmultang on Learning and Memory of AD Rats using Morris water maze paradigm

향부자팔물탕(香附子八物湯)이 Alzheimer's disease 모델 백서(白鼠)의 학습과 기억에 미치는 영향(影響)

  • Kang Hyun-Geun (Dept. of Oriental Neuropsychiatry, College of Oriental Medicine, Kyung Hee University) ;
  • Kim Jong-Woo (Dept. of Oriental Neuropsychiatry, College of Oriental Medicine, Kyung Hee University) ;
  • Whang Wei-Wan (Dept. of Oriental Neuropsychiatry, College of Oriental Medicine, Kyung Hee University)
  • 강현근 (경희대학교 한의과대학 신경정신과 교실) ;
  • 김종우 (경희대학교 한의과대학 신경정신과 교실) ;
  • 황의완 (경희대학교 한의과대학 신경정신과 교실)
  • Published : 1999.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

The effects of Hyangbujapalmultang on the enhancement of learning and memory of AD model rats were studied with Morris water maze. Sample group was electrolytically lesioned on nucleus basalis of Meynert(nbM), and then daily treated with the medicine for two months. Control group with nbM lesion, and sham group with the sham operation were treated the vehicle for the same duration. The following results were observed. 1. As the learning trials of Morris water maze were proceeded, sham group showed the escape latency from $54.7{\pm}2.28$ seconds in 1st trial to $13.3{\pm}3.27$ seconds in 7th. The control group showed the escape latency from $58.0{\pm}1.78$ seconds in 1st trial to $51.3{\pm}3.52$ seconds in 7th. The sample group showed the escape latency from $57.0{\pm}2.21$ seconds in 1st trial to $28.4{\pm}4.82$ seconds in 7th. Therefore, these data shows that all three groups were improved in learning capacity as trials were proceeded, but the sample group showed more prominent improvement in learning compared with the control group(p<0.05). 2. In memory retention test of Morris water maze that counts the staying time in the target area during 30 seconds of freely swimming period, sham group stayed for $4.81{\pm}1.15$ seconds, the control group stayed for $1.27\pm}0.78$ seconds, and the sample group stayed for $4.17{\pm}1.47$ seconds. The analysis of the memory retention data shows that the sample group marked more improvement in memory retention compared with the control group, but could not obtained statistically significant result(p<0.05). With the experimental results above, Hyangbujapalmultang can be supposed to have the improving effects on the learning of AD model rats induced by electrolytic lesion of nbM.

Keywords

References

  1. 四象醫學原論 洪淳用;李乙浩
  2. 萬病回春 공延賢
  3. 濟生方 中國醫學大系 中 11卷 嚴用和
  4. 陜西中醫 v.16 no.9 百家論醫 老年性痴매從肝論治 李曉玲
  5. 丹溪醫集 중 丹溪心法 朱震亨
  6. 神經內科中醫治療全書 蔡예(외3인)
  7. 上海中醫藥雜誌 v.5 24例老年性痴매臨床觀察 徐仕珍
  8. 上海中醫藥雜誌 v.4 中醫治療老年腦血栓形成後痴매 李貫徹;孟祥福;李光
  9. 安徽中醫學院學報 v.15 no.1 滌痰化瘀湯治療腦血管性痴매15例 李中南;王正雨;王健平
  10. 上海中醫藥雜誌 v.3 매從痰治 張覺人
  11. 上海中醫藥雜誌 v.1 中風痴매 從痰瘀論治 鄭功澤;周鶯歌
  12. 浙江中醫學院學報 v.19 no.3 淺談老年痴매症的治療 許曉蓉
  13. 上海中醫藥雜誌 v.3 多發性梗塞性痴매的中醫分型與治療 黃志雄
  14. 韓方基本處方集 慶熙醫療院韓方病院(編)
  15. 신경정신과학 대한신경정신의학회
  16. 신경전달물질 서유헌
  17. 四象體質醫學論 尹吉榮
  18. 本草學 李尙仁
  19. 東醫壽世保元 李濟馬
  20. 本草學 全國韓醫科大學 本草學敎授(共編著)
  21. 原本東醫寶鑑 許浚
  22. 精校黃濟內經 洪元植(編)
  23. 동의정신의학 황의완(외)
  24. 계명의대논문집 v.6 no.3 Alzheimer병의 진단적 평가 김도관;노주선
  25. 香附子八物湯이 구속Stress 흰쥐의 체중 및 혈장 Catecholamine 함량에 미치는 영향 김성욱
  26. 가정의학회지 v.18 no.3 치매의 접근 방법 나덕렬
  27. 신경정신의학 v.28 no.3 노인용 한국판 Mini-Mantal State Examination (MMSE-K)의 표준화 연구 -제2편:구분점 및 진단적 타당도- 박종한;권용철
  28. 계명의대논문집 v.16 no.3 노화에 관련된 인지기능 감퇴 박종한;김희철
  29. 계명의대논문집 v.16 no.3 Alzheimer병의 신경병리학적 소견과 분자생물학적 연구동향 손윤경
  30. 계명의대논문집 v.16 no.3 Alzheimer병 연병길;박종한
  31. 대한정신약물학회지 v.7 no.2 노인정신장애의 치료-인지장애 알츠하이머 치매환자의 약물치료 중심으로- 오병훈
  32. 계명의대논문집 v.16 no.3 Alzheimer병의 정신사회적 치료 오병훈
  33. 신경정신의학 v.35 no.6 알츠하이머병의 말초 생물학적 지표로서 혈청 Alpha-1-antichymotrypsin 우종인(외2인)
  34. 신경정신의학 v.36 no.1 한국의 한 농촌 지역에 거주하는 노인에서의 치매의 유병률 우종인(외6인)
  35. 조위승청탕의 학습과 기억에 미치는 영향 우주영
  36. 계명의대논문집 v.16 no.3 Alzheimer병의 약물 치료 우행원
  37. 대한정신약물학회지 v.7 no.2 노인정신병의 약물치료 윤도준
  38. 香附子八物湯이 구속스트레스 흰쥐의 항스트레스와 면역반응에 미치는 영향 이승기
  39. 調胃升淸湯이 Alzheimer’s disease 모델 백서의 학습과 기억에 미치는 영향 이웅석
  40. 대한정신약물학회지 v.8 no.1 에스트로젠과 알쯔하이머병 이종섭(외1인)
  41. 경희의학 v.13 no.1 치매 장대일
  42. 한국심리학회지 v.5 내측중격핵 손상이 morris 수중미로과제의 학습에 미치는 효과 정봉교;윤병수;박순권
  43. 荊防地黃湯이 Alzheimer’s disease 모데 백서의 학습과 기억에 미치는 영향 조윤숙
  44. 스트레스에 의한 백서의 병리변화 및 香附子八物湯의 효능에 관한 실험적 연구 한성규
  45. 스트레스에 의한 백서의 병리변화 및 香附子八物湯의 효능에 관한 실험적 연구 한성규
  46. 소음인 香附子八物湯의 항스트레스 효과에 관한 실험적 연구 홍주희
  47. 경희의학 v.12 no.2 치매에 관한 한의학적 임상연구 황의완(외4인)
  48. 濟衆新編 康命吉
  49. 中藥大辭典 江蘇新醫學院(編)
  50. 中草藥學 上海中醫學院(編)
  51. 醫宗必讀 李中梓
  52. 醫學入問(全五卷中二) 李挻
  53. 景岳全書 張介賓
  54. 辨證奇文全書 錢鏡湖
  55. 實用中西醫結合診斷治療學 陳貴延;楊思澍
  56. 石室秘錄(下) 陳士澤
  57. Diagnotic Neuroradiology Anne G. Osborne
  58. DSM Ш-R APA(American Psychiatric Association)
  59. Pathophysiology : adaptation and alterations in function 4th edition Barbara L. Bullock
  60. Harrison’s Principles of Internal Medicine 11th edition Eugene Braunwald(외)
  61. Atlas of clinical neurology 2nd edition G. David Perkin;Fred H. Hochberg
  62. General and systemic pathology 2nd edition Underwood, J. C. E.
  63. Cecil Texbook of Medicine(17th edition) James B. Wyngaarden(외)
  64. Medical Neurology(3rd edition) John Stirling Meyer
  65. Merritt’s Texbook of Neurology(7th edition) Lewis P. Rowland
  66. Neurobiology of the hippocampus An attempt to dissociate “spatial-mapping” and “working-memory” theories of hippo-campal function Morris, R.G.M.;Seifert, W.(Ed.)
  67. Brain cholinergic systems Seriade, M.;Bielsold, D.
  68. Neurobiology of the hippocampus Memory function and the hippo-campus Olton, D.S.;Seifer, W.(Eds.)
  69. Cent Nervenheilk Psychiat v.30 Ueber eine eigenartige Erkrankung der Hirnrinde Alzheimer, A.
  70. J Am Geriater Soc v.45 no.10 Effect of genetic risk factors and disease progression on the cerebrospinal fiuid tau levels in Alzheimer’s disease Arai, H.(et al)
  71. Journal of Neurochemistry v.44 Changer of biogenic amines and their metabolites in postmortem brains form patients with Alzheimer-type dementia Arai, H.;Kosaka, K.;Iizuka, R.
  72. Brain Res v.622 no.1;2 Galanin fails to alter both acquisition of a two trial per day water maze task and neurochemical markers of cholinergic or serotonergic neurones in adult rats Aspley, S.;Fone, K.C.
  73. Neusci Lett v.247 no.1 Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer’s disease in Chinese Baum, L.(et al)
  74. J Altern Complement Med v.3 no.4 Effects of Trasina, an ayurvedic herbal formulation, experimental models of Alzheimer’s disease and central cholinergic markers in rats Bhattacharya, S.K.;Kumar, A.
  75. Br J Clin Psychol. v.36 Single case evaluation of the effects of aromatherapy and massage on disturbed behaviour in severe dementia Brooker, D.J.(et al)
  76. Neurosci Lett v.241 no.1 No association detected between very-low-density lipoprotein receptor and late-onset Alzheimer’s disease in Hong Kong Chinese Chen, L.(et al)
  77. Brain Res. v.679 no.1 Anabolic-androgenic steroid and adrenal steroid effects on hippocampal plasticity Clark, A.S.;Mitre, M.C.;Brinck-Johnsen, T.
  78. Neuroepidemiology v.16 no.1 Cognitive predictors of dementia in elderly community residents Dartigues, J.F.(et al)
  79. Brain Res v.572 no.1;2 Effects of nicotine on a spatial memory deficits in rats with septal lesions Decker, M.W.;Majchrzak, M.J.;Anderson, D.J.
  80. Brain Res v.544 no.1;2 Spatial performance correlates with in vitro potentiation in young and aged Fischer 344 rats Deupree, D.L.;Turmer, D.A.;Watters, C.L.
  81. J Neuropathol Exp Neurol v.56 The pathogenesis of senile plaque Dickson, D.W.
  82. JAMA v.278 no.16 Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease Farrer, L.A.(et al)
  83. J Pharmacol Exp Ther v.257 no.1 (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5, 3’) quinuclidine, an Ml selective cholinergic agonist, attenuates congnitive dysfunctions in an animal model of Alzheimer’s disease Fisher, A.(et al)
  84. pediatr Res. v.39 no.1 Use of the Morris water maze and acoustic startle chamber to evaluate neurologic injury after asphyxial arrest in rats Hickey, R.W.(et al)
  85. Nihon Shinkei Seishin Yakurigaku Zasshi v.18 no.2 Recent advances in Alzheimer’s disease research Hirai, S.
  86. Trend Neurosci v.20 Amyloid, the presinalins & Alzheimer’s Ds. Hardy, J.
  87. J Biol Chem v.272 no.4 Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer’s disease Hoshi M.(et al)
  88. Am J Chin Med v.34 no.3;4 Regulatory effect of danguishaoyaosan on central cholinergic nervous system dysfunction in mice Itoh, T.(et al)
  89. Neurology v.49 no.3 Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia Katzman, R.(et al)
  90. FASEB J v.5 advances in Alzheimer’s disease Katzman, R.;Saitoh, T.
  91. Neurology v.50 no.2 Dementia mortality followback survey Lanska, D.J.
  92. Neuroreport v.9 no.3 Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system Lin, L.(at al)
  93. Life Science v.62 no.9 EGG phosphatidylcholine combined with vitamin B12 improved memory impairment following lesioning of nucleus basalis in rats Masuda, Y.(et al)
  94. Nippop Renen Igakkai Zasshi v.34 no.2 Dementia-causes, diagnosis, treatment, and care Morimatsu, M.
  95. Jpn J Pharmacol v.73 no.1 Continuous infusio of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration Nitta, A.(et al)
  96. Eur J Epidemiol. v.13 no.3 Prevalence and risk factors of dementia and clinically diagnosed Alzheimer’s disease in Provence Obadia, Y.(et al)
  97. Neuroscience v.51 no.1 Evidence for a role of the neuropeptide galanin in spatial learning [letter] Ogren, S.O.(et al)
  98. Brain Research Bulletin v.25 Dementia: Animal models of the cognitive impairments following damage to the basal forebrain cholinergic system Oltom, D.S.
  99. Rev Neurol. v.153 no.3 Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area Orgogoza, J.M.(et al)
  100. The rat brain in stereotaxic coordinates Paxinos, G.;Watson, C.
  101. Biol Psychiatry v.43 no.6 Effects of “isolated” transcutaneous electrical nerve stimulation on memory and affective behaviour in patients with probable Alzheimer’s disease Scherder, E.J.(et al)
  102. Neurochem Int no.2 Systemic administration of defined extracts form Withania somnifera(Indian Ginseng)and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain Schiebs, R.(et al)
  103. Science v.275 Alzheimer’s disease; Genotypes, phenotypes, and treatments Selkoe, D.J.
  104. Pharmacol Biochem Behav v.59 no.1 Ameliorative effect of SA4503, a novel cognitive enhancer, on the basal forebrain lesion-induced impairment of the spatial learning performance in rats Senda, T.(et al)
  105. Seishin Shinkeigaku Zasshi v.99 no.8 Apolipopretein e genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer’s disease Shimada, K.(et al)
  106. J Pharmacol Exp Ther v.280 no.2 Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer’s disease Smith, C.P.(et al)
  107. Effects of chronic substance P treatment and intracranial fetal grafts on learning after hippocampla kanic acis lesions Peptides v.17 no.2 Sprick, U.(et al)
  108. Brain Res v.726 no.1;2 Biphasic effect of tacrine on acetylcholine release in rat brain M1 and M2 receptors Svensson, A.L.;Zhang, X.;Nordberg, A.
  109. Behav Brain Res v.83 no.1;2 A novel proply1 endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer’s disease Toide, K.(et al)
  110. Brain Res v.582 no.2 Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats Torre, J.C.(et al)
  111. Rinsho Shinkeigaku v.37 no.12 Advance in the research on Alzheimer’s disease-overview Tsuji, S.
  112. Nippon Koshu Eisei Zasshi v.44 no.9 Intakes and health effects of aluminum, “Is aluminum a risk factor for Alzheimer’s disease? Uchida, H.;Nagai, M.
  113. Dement Geriatr Cogn Disord. v.9 no.5 Epidemiologic and Genetic Studies of Dementia of the Alzheimer’s Type in Japan Urakami, K.(et al)
  114. J Neurol Sei v.147 no.1 Autosomal dominant early onset dementia and leukoencephalopathy in a Japanese family: clinical, neuroimaging and genetic studies Utatsu, Y.(et al)
  115. Brain Res v.726 no.1;2 Injection of IgG 192-saporin into the medial septum produces cholinergic hypofunction and dose-dependent working memory deficits Walsh, T.J.(et al)
  116. Brain Res v.702 no.1;2 Behavioral and neurobiological alterations induced by the immunotoxin 192-IgG-saporin: cholinergic and non-cholinergic effects following i.c.v. injection Walsh, T.J.(et al)
  117. Psychopharmacol Bull v.33 no.1 Dementia drug development : use of information systems to harmonize global drug development Whitehouse, P.J.(et al)
  118. Int Psychogeriatr. v.9 no.2 Age of onset and brain atrophy in Alzheimer’s disease Woo, J.I.(et al)
  119. J Phamacol Exp Ther v.272 no.1 FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze Yamazaki, M.(et al)
  120. J Cereb Blood Flow Metab v.16 no.5 Spatial memory disturbance after focal cerebral ischemia in rat Yonemori, F.(et al)